Abstract
An improvement to a functional module for the selective application of substances inside fertile eggs represents an inventive solution in the field of poultry fanning, in particular in the field of poultry breeding, and more specifically in the step of application of vaccines and/or nutrients into fertile eggs by injection, this improvement reducing the risk of violation of biological safety, and ensuring the integrity and survival of the embryo (Em), limiting intra-ovum nutritional supplementation to the amniotic fluid (Li) only, without contact of the needle (a13) with the embryo (Em), and to achieve this condition the module for the selective application of substances inside fertile eggs (Ov) has a structure composed of an injector selector submodule (m1), a selective operation actuation submodule (m2), a speed control submodule (m3) and a common perforator/needle return submodule (m4).
Claims
1. Improvement applied to the functional module for selective application of substances inside fertile eggs, wherein a substance application module is formed by a horizontal displacement platform (Ph) which positions a tray (b) with niches (b1) of shape aligned with the matrix of injector devices (Mi), a vertical displacement platform (Pv) that supports the injector matrix (Mi), whose injectors have a technological base formed by a needle coupler (a1), a nutrient connector (a2), a sanitizing connector (a3), a punch feed cylinder (a5), a needle feed cylinder (a7), a straight pneumatic connection (a8), a cover (a9) a casing (a10), a plunger (a11), a M5 punch (a12) and a needle (a13) in which the architecture of the improved substance application module is characterized in that it is composed by an injector selector sub-module (m1) which sends signal to the selective operation actuation sub-module (m2) in the form of a dedicated valve (Va1), notably an individual 3/2-way valve connected to the needle feed cylinder (a7) and to the punch feed cylinder (a5), a speed control sub-module (m3) being further defined in the form of a needle speed feed control valve (Va2) acting adjacent to the needle feed cylinder (a7) and further defining a collective punch/needle return sub-module (m4) in the form of a collective valve (Va3), notably a collective 3/2-way valve coupled to the punch feed cylinders (a5) and needle feed cylinders (a7) of all the injector devices (A).
2. Improvement applied to the functional module for selective application of substances inside fertile eggs according to claim 1, wherein once operative, the needle feed cylinder (a7) is characterized in that it moves the needle (a13) at an ideal feed rate (V1) that should be 35 mm per second.
Description
DESCRIPTION OF THE FIGURES
[0046] To complement the present description in order to obtain a better understanding of the features of the present invention, and according to a preferred practical embodiment thereof, the description is accompanied by a set of appended drawings, wherein:
[0047] FIG. 1 is an illustrative representation in perspective of the constructive concept of the module for the application of substances to fertile eggs anticipated by the state of the art, with reference to FIG. 2 of U.S. Pat. No. 6,286,455, highlighting the main component parts;
[0048] FIGS. 2a and 2b are an illustrative representation inside view of the module concept for the application of substances in fertile eggs, as anticipated by the state of the art, showing the beginning of the operative procedure of injection of substances into a matrix formed by the accommodation tray of fertile eggs, considering that there are niches with absence of eggs, immediately before and after their activation respectively, revealing the problem of biological safety risk and unnecessary injection of substances;
[0049] FIG. 3 is an illustrative side view of the constructive concept of the fertile egg application module anticipated by the state of the art, with reference to FIG. 1 of
[0050] U.S. Pat. No. 6,286,455, showing the main components as well as the logic of its operational drive, evidencing the problem of the collective activation of all injection devices of the device matrix;
[0051] FIG. 4 is an illustrative side view of the constructive concept of the fertile egg application module anticipated by the state of the art, with reference to FIG. 3 of U.S. Pat. No. 6,286,455, showing the main components as well as the logic of its operational drive, evidencing the problem of the collective activation of all injection devices of the device matrix;
[0052] FIGS. 5a and 5b are illustrative in side view representations of the concept of the improved application module of substances in fertile eggs, showing the beginning of the operative procedure of injecting substances into a matrix formed by a tray of fertile eggs, in which there are niches with absence of eggs immediately before and after their activation respectively, and revealing the problem of biological safety risk and unnecessary injection of substances;
[0053] FIG. 6a is an illustrative front view of the differential injection device for substances, showing its external component parts;
[0054] FIG. 6b is an illustrative representation in the rear view of the differential injection device for substances, showing its external component parts;
[0055] FIG. 6c is an illustrative cross-sectional view of the differential injection device for substances, showing its external and internal component parts;
[0056] FIG. 7a is an illustrative representation of the individual activation subsystems of the individual displacement and velocity control for each needle as well as the collective retraction subsystem of the needle matrix;
[0057] FIG. 7b is an illustrative representation of component parts of the individual activation subsystems and of individual displacement velocity control for each needle as well as the collective return subsystem of the needle matrix;
[0058] FIG. 8a is an illustrative illustration of the needle feed operation of a conventional injection device, useful for injection of vaccines, but not indicated for the inoculation of nutrients, showing that in this condition, penetration of the needle bevel occurs in the body of the embryo;
[0059] FIG. 8b is a graphical representation showing the evolution of approaching velocity: from the components of the collective needle valve assembly, from the support platform of the injector matrix and needle feed cylinder to the conventional needle injection, suitable for the injection of vaccines;
[0060] FIG. 9a is a graphical representation of the evolution of approach velocity: from the components of the individual needle valve, punch feed cylinder and the needle feed cylinder, to each injection device of the matrix of devices, suitable for inoculation of vaccines and nutrients; and
[0061] FIG. 9b is an illustrative representation of the needle feed operation of an improved injection device, useful for inoculating vaccines and nutrients into the amniotic fluid, showing that, in this condition, there is no penetration of the needle bevel into the body of the embryo.
DETAILED DESCRIPTION
[0062] The following detailed description should be read and interpreted with reference to the presented drawings, not intended to limit the scope of the invention, this being limited only as explicit in the content of the claims.
[0063] a.1 State of the art:
[0064] As shown in FIG. 1, the conventional fertilizing egg substance (Et) module is composed essentially of the following devices: [0065] horizontal displacement platform (Ph): has the function of providing the displacement and positioning of the tray (b) in a way aligned with the matrix of injector devices (d); [0066] tray (b), provided with a plurality of niches (b1) in which the fertile eggs (Ov) are accommodated; [0067] vertical displacement platform (Pv): it has the function to provide the assembly and stabilization of the injector matrix (Mi), also providing its vertical displacement; [0068] injection devices (In): with the purpose of providing injection of substances, notably vaccines, consisting basically of an input for needle advancement (In7) and another for return, being a pneumatic double acting cylinder system (In4), whose actuation is collective for all injectors (In) of the matrix, by means of single collective control valve (Va), see FIGS. 3 and 4. The punch (In6) is introduced into the egg (Ob) by mechanical actuation of the vertical displacement (Pv), where the injectors (In) are aligned above the eggs (Ov), see FIGS. 2a and 2b. In turn, at the top of each injector (In) is defined a substance access connector (In3) and a connector for sanitizing the access of the substance (In2);
[0069] The punch (In6) and needle end (In7) components, when in non-operational condition, are collected inside the casing or head (In5);
[0070] a.2 Evidenced problem: as shown in FIGS. 2a and 2b, in operative condition, all needles (In7) are driven in vertical movement away from the head (In5), where effectively independent of the presence of fertile eggs (Ov) in the niches (b1) of the tray (b), becoming evident the exposure to the external environment of the ends of the needles (In7) in the niches (b1) with absence of fertile eggs (Ov), converging to a biological safety risk, since this exposure can lead to the contamination of the substance retained in the needle (In7) that migrates to the substance reservoir, thus generating loss and financial loss.
[0071] a.3 Cause of the problem: the scenario described above only occurs because of the constructive concept of collective activation of the downward vertical movement of the needles, which is controlled by a collective 5/2-way valve (Va), where a connection (v4) is provided which activates the forward signal of the needles (In7) of each injector (In), and a connection (v2) which activates the needle retraction signal (v2) of each injector (In) of the injector matrix.
[0072] b. About the improved substance application module: it has been designed so that the objects of the invention are practicable to actuate the needles only from the injectors (A) having a corresponding fertile egg (Ov) thereon, as shown in FIGS. 5a and 5b, and further in addition that the said forward activation is done at controlled speed, wherein for this purpose the injector matrix is formed by a plurality of improved injectors (A), whose constructive concept is disclosed in FIGS. 6a; 6b and 6c, and formed from the functional components:
[0073] b.1 Base technology (provided in the conventional gun): [0074] needle coupler (a1); [0075] nutrient connector (a2); [0076] sanitizing connector (a3); [0077] punch feed cylinder (a5); [0078] needle feed cylinder (a7); [0079] straight pneumatic connection (a8); [0080] cover (a9); [0081] casing (a10); [0082] plunger (a11); [0083] M5 punch (a12); and [0084] needle (a13).
[0085] b.2: Introduced improvements: [0086] Injector selector sub-module (m1): as shown in FIGS. 7a and 7b, in the form of a selector device (Se), where it sends a signal to the selective operation actuation sub-module (m2); [0087] Selective operation actuation sub-module (m2): as shown in FIGS. 7a and 7b, wherein in a preferred embodiment it is specified as a dedicated valve (Va1), notably an individual 3/2-way valve for the advancement of each punch (a12) and respective needle (a13), which is connected to the needle feed cylinder (a7) and punch feed cylinder (a5); [0088] Speed control sub-module (m3): as shown in FIGS. 7a and 7b, wherein in a preferred embodiment it is specified as a needle speed feed control valve (Va2) acting adjacent to the needle feed cylinder (a7). Effectively, the needle displacement speed (a13) must be controlled to 35 mm per second. [0089] Collective punch/needle return sub-module (m4): as shown in FIGS. 7a and 7b, wherein in a preferred embodiment it is specified as a collective valve (Va3), notably a collective 3/2-way valve for return of the punch feed cylinders (a5) and the needle feed cylinders (a7) of all injectors (A).
[0090] C. The technical effect obtained:
[0091] c.1 Selective inoculation of substances: as shown in FIGS. 5a and 5b, where only are activated the punch feed cylinder (a5) and the needle feed cylinder (a7) of the injectors (In) of the matrix in which the presence of fertile eggs is identified (Ov) in niche (b1) of tray (b), eliminating undue exposure of needles (a13) by eliminating the risk (Ri) of substance contamination (vaccine, nutrients, among others), see FIG. 5b;
[0092] c.2 Preservation of the embryo under nutritional supplementation: as shown in FIG. 8a wherein for nutritional supplementation there is a need to control the feed rate (V1) of the needle (a13) inside the fertile egg (Ov), ensuring a safety condition (Co1), where there is no needle penetration (a13) into the embryo tissue (Em), so that the nutrient is released only in the amniotic fluid (Li). In addition, FIG. 8b shows the obtained feed rate (V1) necessary for the dedicated valve (Va1), needle feed cylinder (a5) and punch feed cylinder (a7), in order to obtain the safety condition (Co1).
[0093] Optimum feed rate (V1) should be 35 mm per second.
[0094] Only for comparative purposes, FIG. 9a shows a condition of a vaccination procedure, where the condition is allowed and desired (Co2) with needle penetration (a13) into the embryo musculature (Em). FIG. 9b shows the feed rate condition (V2) commonly observed in the vaccination procedure, for the collective valve (Va), vertical displacement platform (Pv) and needle feed cylinder (a5).
[0095] The choice of the preferred embodiment of the invention claimed in this carton, described in this detailed section, is given by way of example only. Any changes, modifications, and variations may be made to any other embodiments of the improved substance application module and corresponding improved injector device (A), which comprises the injector matrix, wherein changes may be designed by those skilled in the art, however without diverging from the object disclosed in the application of the present patent, which is exclusively defined by the annexed claims.
[0096] It is seen from what has been described and illustrated that the IMPROVEMENT APPLIED TO THE FUNCTIONAL MODULE FOR SELECTIVE APPLICATION OF SUBSTANCES INSIDE FERTILE EGGS heretofore claimed falls within the rules governing the patent in the light of the Industrial Property Law, thus deserving of what has been stated and as a consequence, the respective privilege.
